BBP-398
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BBP-398, covering 2024-06-25 to 2024-12-12. Get the full timeline:
Most recent: Clinical Trial Update: SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation [Phase 1]